Therapeutic Areas
We provide integrated bioanalytical solutions across all therapeutic and speciality areas.
We employ a hands-on, end-to-end approach, collaborating closely with our clients to deliver integrated bioanalytical solutions across all therapeutic areas.
The services we provide to biotech and pharmaceutical organizations, researchers, and healthcare professionals, are supported by extensive scientific expertise, a commitment to quality, and cutting-edge bioanalytical platforms.
We understand the unique challenges that may arise at each stage of drug development, from the preclinical to post-market approval phases, and we bring together different analytical techniques or tools to address them effectively. This interconnectedness and synergy between various aspects of our services result in a more cohesive and holistic solution for your needs and enable us to give thorough attention to every aspect of your project.
THERAPEUTIC FOCUS
Immunology
Immunology encompasses a diverse range of conditions from autoimmune disorders to infectious diseases.
From immune profiling using advanced omics technologies to preclinical and clinical trial support for immunotherapy development, Firalis Molecular Precision (FMP) plays a major role in advancing research and accelerating immunotherapy development.
Our services, including immune cell characterization, biomarker discovery, immunogenicity assessment, and immunomonitoring, help translate scientific advancements into effective therapies that improve patient outcomes.
Oncology
With a wide range of treatment therapies emerging, from chemo- and radiotherapy to novel immuno- and targeted therapies, the oncology landscape is ever-evolving.
Here, our role as a CRO partner is to provide a holistic multi-omics approach enabling researchers and clinicians to identify key molecular drivers of cancer progression and treatment response.
FMP paves the way for more effective and personalized treatments and optimized patient care.
Cardiology
Cardiology involves the diagnosis and management of various cardiovascular diseases, including coronary artery disease, heart failure, and arrhythmias.
In this context, you need a CRO’s support when you conduct clinical trials to assess the efficacy and safety of cardiovascular drugs.
FMP aids you by accelerating the development of these life-saving treatments and improving outcomes for patients with heart-related conditions.
Neurology
Neurology encompasses conditions ranging from neurodegenerative diseases like Alzheimer’s and Parkinson’s to neurological disorders such as epilepsy and multiple sclerosis.
As a CRO partner, FMP assists companies developing neurology-related drugs and treatments, by providing biomarker discovery and cell characterization services that enable early diagnosis, prognosis, and treatment response monitoring.
Dermatology
Being focused on the diagnosis and treatment of skin disorders, dermatology covers a broad spectrum of conditions including acne, eczema, psoriasis, and skin cancer.
FMP’s experience and scientific expertise is crucial in supporting the clinical trials our sponsors conduct to assess the safety and efficacy of topical treatments, biologics, and other dermatological therapies.
Inflammation
Biopharmaceutical organizations and researchers seek to identify potential therapeutic targets and develop personalized treatment strategies for chronic conditions such as rheumatoid arthritis, inflammatory bowel disease and asthma.
Therefore, they need the assistance of a reliable CRO with significant scientific expertise in inflammatory biomarker discovery, immune cell profiling and cell and tissue transcriptomic and proteomic analyses to drive novel treatment development for inflammatory disorders.
Respiratory diseases
Respiratory diseases often involve inflammation and structural changes in the airways and have associated molecular markers.
To analyze these markers and gain a deeper understanding of the diseases, services – such as NGS, single-cell RNA sequencing, and spatial transcriptomics – are offered by FMP.
These advanced techniques are used to characterize the composition and gene expression profiles of airway epithelial cells, immune cells, and structural cells in the lungs, and thereby provide insights into the cellular mechanisms underlying respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis.
OUR EXPERTISE
At Firalis Molecular Precision, we stand as a steadfast partner to organizations shaping the future of biotechnology and precision medicine, offering support to our sponsors throughout their drug development and research journeys.
Every step of the way, we bring forth the right blend of cutting-edge technologies, innovative solutions and specialized expertise to navigate the challenges of these processes.
From disease biomarker discovery to post-market surveillance, trust Firalis Molecular Precision to be your reliable collaborator, ensuring precision and innovation at every phase of your research projects.
